A phase 2 open-label pilot study of Remimazolam for sedation in critically ill patients

Published in: Anaesthesia Critical Care & Pain Medicine

Volume 44, Issue 3, pp. 101510-101510

DOI: 10.1016/j.accpm.2025.101510